1. Adelaide Research & Scholarship

Browsing "Pharmacology publications" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 92 to 111 of 918 < previous   next >
PreviewIssue DateTitleAuthor(s)
2021Are sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk?Sui, S.X.; Hordacre, B.; Pasco, J.A.
1995Aspirin for myocardial infarction: Clinical pharmacokinetic considerationsBochner, F.; Lloyd, J.
2009Aspirin for primary prevention: do potential benefits outweigh the risks?Shakib, S.
1996Aspirin: How low is low dose?Lloyd, J.; Bochner, F.
2003Assembly of PRR-containing receptors on scaffolds: a model for imidazoline I1-receptor actionMusgrave, I.; Dehle, F.; Piletz, J.; Piletz, J.E.; Regunathan, S.; Ernsberger, P.
1999Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.Sallustio, B.; Morris, R.
2018Assessment of pain-related fear in individuals with chronic painful conditionsMittinty, M.; McNeil, D.; Brennan, D.; Randall, C.; Mittinty, N.; Jamieson, L.; Schatman, M.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.
2006Association between the DRD2 A(1) allele and response to methadone and buprenorphine maintenance treatmentsBarratt, D.; Coller, J.; Somogyi, A.
2009Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependenceLiu, L.; Hutchinson, M.; White, J.; Somogyi, A.; Coller, J.
2014Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaMulholland, C.; Somogyi, A.; Barratt, D.; Coller, J.; Hutchinson, M.; Jacobson, G.; Cursons, R.; Sleigh, J.
2009Associations between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with TamoxifenSchroth, W.; Goetz, M.; Hamann, U.; Fasching, P.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.; Ames, M.; Safgren, S.; Kuffel, M.; Ulmer, H.; Bolander, J.; Strick, R.; Beckmann, M.; Koelbl, H.; Weinshilboum, R.; Ingle, J.; Eichelbaum, M.; et al.
2011Attenuating glial activation with minocycline reduces the hyperthermic response to 3, 4-methylenedioxymethamphetamine (MDMA) in the ratAnderson, P.; Hutchinson, M.; Irvine, R.; Salem, A.
2001Attenuation of morphine withdrawal signs by the GABAB receptor agonist baclofenBexis, S.; Ong, J.; White, J.
1996Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodoneMaddocks, I.; Somogyi, A.; Abbott, F.; Hayball, P.; Parker, D.
2005The Australasian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteineKerr, Fergus; Dawson, Andrew; Whyte, Ian M.; Buckley, Nicholas Allan; Murray, Lindsay; Graudins, Andis; Chan, Betty; Trudinger, Barbara
1998Australian Medicines HandbookBochner, F.
2016Authors’ reply to Palozzo and Messori: ‘‘Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review’’Parkinson, B.; Elshaug, A.G.
2010Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expressionHennig, G.; Gehrmann, M.; Stropp, U.; Brauch, H.; Fritz, P.; Eichelbaum, M.; Schwab, M.; Schroth, W.
2002a₂-Adrenergic agonists in opioid withdrawalGowing, L.; Farrell, M.; Ali, R.; White, J.
Showing results 92 to 111 of 918 < previous   next >